KathrynEDusenberyMD

Radiation Oncology • Minneapolis, MN

Gynecologic Cancer, Pediatric Radiation Oncology, Sarcoma

Professor

Join to view full profile

Dr. Dusenbery is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dusenbery's full profile

Already have an account?

Office
500 Harvard St Se
University Of Minnesota Physicians
Minneapolis, MN 55455
Phone+1 612-273-6700

Education & Training

University of MinnesotaResidency, Radiation Oncology, 1987 - 1990
University of MinnesotaFellowship, Hematology and Medical Oncology, 1985 - 1987
Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1982 - 1985
Wayne State University School of MedicineClass of 1982

Certifications & Licensure

MN State Medical License 1985 - 2025
MI State Medical License 1983 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014-2022
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies Start of enrollment: 2014 Sep 02
Recruiting
Not Applicable
Post-contracture Release Radiation for Dupuytren's Disease Start of enrollment: 2019 May 31
Recruiting

Publications & Presentations

PubMed

ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome.
Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain
Transplantation and Cellular Therapy. 2024-11-01
Early experience and perioperative risk of GammaTile for upfront brain metastases: Report from a prospective multicenter study.
Sabrina L Zeller, Sauson Soldozy, Shaye Busse, Clark C Chen, Andrew Venteicher
Neuro-Oncology Advances. 2024-09-10
Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field.
Kevin X Liu, Sherif G Shaaban, Jie Jane Chen, Rochelle Bagatell, Benjamin J Lerman
Radiotherapy and Oncology. 2024-09-01

Press Mentions

University of Minnesota First in U.S. To Offer New Targeted Therapy for Recurrent Brain TumorsFebruary 14th, 2019
Decision-Making Input Linked to More Satisfied Cancer PatientsApril 23rd, 2014
Seymour H. Levitt, MD, 1928-2017February 9th, 2018